Tag: Science

news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
news-19112024-001706

Promising Drugs for Lipoprotein(a) – Reducing Risk of Heart Disease

Lipoprotein(a) is a lesser-known risk factor for heart disease that can be just as dangerous as high cholesterol. This lipoprotein can lead to plaque build-up in arteries, increasing the risk of heart attacks and...
news-08112024-160107

The Impact of Trump and Robert F. Kennedy Jr. on Vaccine Confidence and Safety:...

Donald Trump's recent win could lead to a significant impact on how vaccines are regulated and distributed in the United States due to the influence of longtime vaccine skeptic Robert F. Kennedy Jr. Kennedy...
news-19112024-061756

Mutations in H5N1 Bird Flu Virus in Canadian Teenager Highlight Risk

The H5N1 bird flu virus that infected a teenager in British Columbia has undergone mutational changes making it easier to infect people, according to scientists. The teenager remains in critical condition in the hospital,...
news-16112024-181031

Understanding RFK Jr.’s Stance on Food, Vaccines, Abortion, and the FDA

President-elect Trump’s announcement that Robert F. Kennedy Jr. is nominated to lead the Department of Health and Human Services has sparked both support and concern. If confirmed by the Senate, RFK Jr. could bring...
news-11112024-034923

FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update

As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
news-01122024-132740

Advancing RNA-Based Drugs in Rare Diseases: Sarepta and Arrowhead Pharmaceuticals Partnership

Sarepta Therapeutics has announced a significant partnership with Arrowhead Pharmaceuticals to develop RNA-based drugs for rare diseases. The deal includes a $500 million cash payment from Sarepta to Arrowhead, along with a $325 million...
news-01122024-004129

Effective Diets and Supplements to Prevent and Manage Cancer: A Comprehensive Guide

Good nutrition is crucial for maintaining good health. A healthy diet should consist of a variety of foods and beverages that provide the necessary nutrients for your body to function properly.Many individuals wonder if...
news-30112024-184059

Managing Ascites in Cancer Patients: Understanding Side Effects

Ascites is the abnormal buildup of fluid in the abdomen, causing swelling. It can be caused by certain types of cancer, especially advanced cancer that has spread to the peritoneal cavity. When cancer cells...
news-30112024-123734

Mysterious Bird Flu Case in British Columbia: What We Know So Far

Health officials in British Columbia, Canada, have concluded their investigation into a mysterious case of a teenager being infected with H5N1 bird flu. The province's public health officer, Bonnie Henry, announced that the investigation...
news-20112024-122223

Apellis Triumphs while Astellas Faces Defeat

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter. Here's what you...
news-19112024-182028

Merck Drug Trial and Wegovy in China: Pharmalittle News Update

Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...